23 Jul, 2026
According to Straits Research, the global eye testing equipment market size was valued at $3.59 billion in 2025 and is projected to grow from $3.84 billion in 2026 to $6.63 billion by 2034, at a CAGR of 7.07% during the forecast period 2026–2034.
Devices that aid eye specialists in diagnosing eye diseases are included in eye testing equipment. Ophthalmologists and optometrists use these instruments for routine eye examinations and identifying specific eye diseases. These instruments are painless, efficient, effective, and accurate for determining eye health status.
Autorefractors, focimeters, slit lamps, biometers, optical coherence tomography (OCT) scanners, and fundus cameras are common eye testing equipment examples. They are utilized to examine eye health and visualize microscopic eye structures. They are also utilized for general eye examinations and the diagnosis of glaucoma, cataracts, and other eye conditions.
Approximately two billion people worldwide live with vision impairment/blindness, with 1.1 billion suffering from vision loss due to lack of eye care access. Several governments have taken initiatives in recent years to reduce the burden of these diseases, thereby increasing the demand for eye apparatus. In 2021, the 74th World Health Assembly made steps to integrate eye care services into national health services fully.
Government services, the private sector, intergovernmental organizations, civil societies, international organizations, and other entities with a stake in the eye care system's transformation all took action. The World Health Assembly states that cataract surgery and refractive errors will be effectively covered by 2030. This includes 40% coverage for refractive error and 30% for cataract surgery. This is anticipated to increase market opportunities as 800 million individuals exhibit myopia, hyperopia, and presbyopia.
Eye diagnostic equipment is continuously evolving in the market. Every year, market participants develop new devices that provide opportunities for eye examination and market expansion. For example, during the COVID-19 pandemic, government-mandated restrictions drastically reduced the rate of ocular examinations. A smartphone-based slit lamp was launched in the market to remedy this issue. In ophthalmology, the slit lamp is a crucial tool for eye examinations. Smartphone-based assisted slit lamp variants significantly altered the market.
In addition, Haag Streit UK, a market leader in eye examination, introduced the Eyesi Slit lamp Fundoscopy module to the UK in 2021. Connect the Eyesi Slit Lamp simulator with this new VRmagic module for a realistic experience. Nidek introduced the retina scanning Duo 2 OCT fundus camera system in 2021. In addition to being simple to use, it includes new features that improve clinical effectiveness and screening capabilities. The device can also improve the technique for denoising B-scan images.
North America is the most significant global eye testing equipment market shareholder and is estimated to exhibit a CAGR of 6.42% over the forecast period. North America is a developed region for healthcare services. Large adoption of advanced products in eye care services and high expenditure are driving the market growth in North America. In addition, increasing awareness and the growing geriatric population are expected to expedite the market growth during the forecast period. As per an analysis by the Population Reference Bureau, the US population over 65 is projected to double from 2018 to 2060, from 52 million to 95 million.
Europe is expected to exhibit a CAGR of 6.63% over the forecast period. Vision impairment is a common eye disease in Europe, with increasing prevalence in Western Europe. Around 8.5 million people in Western Europe suffer from moderate to severe vision loss. Age-related macular degeneration prevalence is 3.5% in people aged 55-59 and 17.6% in 85 and above. By 2040, AMD prevalence will increase from 14.9 million (2019-2020) to 21.5 million 2040, and late AMD is expected to increase from 3.9 million in 2019 to 4.8 million by 2050. In 2020, there were 64 million diabetics in Europe, and nearly one-third had visual impairment. The surging prevalence of diabetes has increased the prevalence of diabetic retinopathy in Europe.
sales@straitsresearch.com